Germany Leads Europe’s Booming Medical Cannabis Market

The German market for medical cannabis continues to grow at an enormous pace. According to recent industry reports, more than 50 tons of medical cannabis were imported into Germany in the first quarter of 2026 alone. This confirms once again that Germany is now the most important market for medical cannabis in Europe.

The figures clearly show how drastically the market has changed since the cannabis reform. While medical cannabis was previously only accessible to a small number of patients, access has now expanded significantly. At the same time, interest from international producers, pharmacies, and investors is steadily increasing.

Reform leads to increased demand

The situation for patients has changed significantly, especially since the partial legalization of cannabis and the simplified prescription requirements. Many people now have faster access to medical cannabis than just a few years ago.

Patients with chronic pain, sleep disorders, neurological conditions, or mental health issues are increasingly turning to cannabis therapies.Experts see this as a crucial turning point for the German market. Cannabis is increasingly perceived as a regular medicine and is slowly losing its former special status.

Germany remains dependent on imports

Despite strong growth, the majority of medical cannabis still comes from abroad. Canada, Portugal, Denmark, and other international producers are particularly significant suppliers to the German market.This highlights a key problem: Germany still lacks sufficient domestic production capacity.

Many companies and industry representatives have therefore been calling for years for the expansion of domestic cultivation projects to reduce supply bottlenecks and dependencies.Especially in recent years, there have been several supply problems in pharmacies. Patients sometimes had to wait weeks for certain types of medication or resort to alternatives.

The economic impact of medical cannabis is growing

With increasing import volumes, the economic importance of the industry is also growing. Pharmacies, wholesalers, producers, and specialized cannabis companies are increasingly profiting from the boom in the medical market.Germany is now considered the most important growth market in Europe.

International companies are specifically aligning their strategies with the German market. At the same time, new jobs are being created in sales, pharmaceutical distribution, logistics, and production.The issue is also likely to gain further political importance. Discussions about domestic cultivation, security of supply, and the future of cannabis legislation will continue to occupy the industry in the coming years.

Europe is watching Germany

While many European countries remain hesitant regarding medical cannabis, Germany is increasingly becoming a role model for regulated cannabis supply. Current import figures clearly demonstrate that the market is no longer a niche sector.

Whether Germany will assume a leading role in production and research in the future depends heavily on the political decisions of the coming years. However, one thing is already clear: the European cannabis market can hardly ignore Germany anymore.

__

(Featured image by 2H Media via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in HanfJournal. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.